✦ LIBER ✦

Risks and benefits of ending of mass screening for neuroblastoma at 6 months of age in Japan

✍ Scribed by Tatsuro Tajiri; Ryota Souzaki; Yoshiaki Kinoshita; Sakura Tanaka; Yuhki Koga; Aiko Suminoe; Akinobu Matsuzaki; Toshiro Hara; Tomoaki Taguchi

Book ID: 116688033
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 107 KB
Volume: 44
Category: Article
ISSN: 0022-3468
DOI: 10.1016/j.jpedsurg.2009.07.050

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mass screening for neuroblastoma at 6 mo

Mass screening for neuroblastoma at 6 months of age

✍ Yuji Miura; Masahiro Kami; Masaharu Tsubokura; Naoko Takei; Tsunehiko Komatsu 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 50 KB

Mass screening for neuroblastoma at 6 mo

Mass screening for neuroblastoma at 6 months of age – Authors' reply

✍ Eiso Hiyama; Tomoko Iehara 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 43 KB

Mass screening for neuroblastoma at 6 mo

Mass screening for neuroblastoma at 6 months of age: Difficult to justify

✍ S Suita; T Tajiri; K Akazawa; Y Sera; H Takamatsu; H Mizote; H Ohgami; N Kurosak 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 483 KB

Insights into infant neuroblastomas base

Insights into infant neuroblastomas based on an analysis of neuroblastomas detected by mass screening at 6 months of age in Japan

✍ Thomas A. Angerpointner 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Results for 79 patients with neuroblasto

Results for 79 patients with neuroblastoma detected through mass screening at 6 months of age in a single institute

✍ NOBUHIRO NISHIO; JUN-ICHI MIMAYA; TAEMI NARA; YOSHIFUMI TAKASHIMA; YASUO HORIKOS 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

German neuroblastoma mass screening stud

German neuroblastoma mass screening study at 12 months of age: statistical aspects and preliminary results

✍ Schilling, Freimut H.; Spix, Claudia; Berthold, Frank; Erttmann, Rudolf; Hero, B 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 1 views

Background. The question of whether screening for neuroblastoma (NB) results in a substantial improvement of the prognosis of the disease is still open. All data, including those of the European pilot studies, indicate the possibility of overdiagnosis in the case of possibly spontaneously regressing